Persistence of this pathological state over time further burdens pancreatic -cells, potentially leading to -cell functional failure and the onset of T2DM (69)
Ever since the FDA gave it the green light (link) for managing weight in obese or overweight adults, the buzz has grown exponentially
For Mounjaro and Wegovy, provide a video of your ID and weight to verify your BMI via your patient record after youve paid
Furthermore, co-treatment with a GLP-1R agonist and a GIPR agonist results in more insulin sensitivity, glucose reduction, food intake reduction, and body weight reduction than either agonist alone in obese mice with type 2 diabetes (33)
The provider reviews BMI, medical history, medications, weight-related health conditions, and treatment eligibility
Provider reviews progress and adjusts protocol